RFC
CADX

Russell Frank Company’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Russell Frank Company’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-623,477
Closed -$6.88M – 2970
2013
Q4 		$6.88M Sell
623,477
-6,974
-1% -$50.4K 0.01% 1051
2013
Q3 		$3.98M Buy
630,451
+10,888
+2% +$69.2K 0.01% 1470
2013
Q2 		$4.23M Buy
+619,563
New +$4.32M 0.01% 1337

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's CADX Position: Q1 2014 in Review

Russell Frank Company sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 623,477 shares — an estimated $6.88M sold.

Russell Frank Company first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $6.88M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Russell Frank Company reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Russell Frank Company sold 623,477 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $6.88M.
  • Russell Frank Company first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Russell Frank Company's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $6.88M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Russell Frank Company's 13F filing for Q1 2014, filed 14 May 2014.